Difference between revisions of "Escitalopram-citalopram"

From Psychiatrienet
Jump to: navigation, search
Line 2: Line 2:
 
| from = Escitalopram
 
| from = Escitalopram
 
| to = citalopram
 
| to = citalopram
| start =
 
 
| stop =  
 
| stop =  
 
*  stop administration abruptly.
 
*  stop administration abruptly.

Revision as of 21:04, 4 March 2010

Escitalopram
Type Antidepressant
Group SSRI
links
Medscape Escitalopram
PubChem 10832572
PubMed Escitalopram
Kompas (Dutch) Escitalopram
Wikipedia Escitalopram
Citalopram
Type Antidepressant
Group SSRI
links
ATC-code N06AB04
Medscape Citalopram
PubChem 2771
PubMed Citalopram
Kompas (Dutch) citalopram
Wikipedia citalopram

Switch medication from Escitalopram to citalopram.[1] [2]

Nietinrijdenbord.png Stop Escitalopram
  • stop administration abruptly.
Eenrichtingbord.png Start citalopram
  • No wash-out period is applied.
  • Start citalopram the next day in the double dosage of escitalopram.
Infobord.png More information
  • Defined Daily Dose citalopram: 20 mg
  • Defined Daily Dose es-citalopram: 10 mg
  • The enantiomers of the racemic mixture citalopram and es-citalopram have qualitatively a quite similar pharmacological effect.
  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.